Turn Therapeutics (Direct Listing) (TTRX) plans to raise $0.00 in an IPO on the week of October 13th, IPO Scoop reports. Turn Therapeutics (Direct Listing) provided the following description of their company for its IPO: “Note: This is a direct listing on the NASDAQ. Background: In its S-1 filing, Turn Therapeutics said its registered stockholders planned to sell up to 8.9 million shares. Turn Therapeutics (Direct Listing) was founded in 2015 and has 2 employees. Receive News & Ratings for Turn Therapeutics (Direct Listing) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Turn Therapeutics (Direct Listing) and related companies with MarketBeat.com's FREE daily email newsletter.